Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Filings indexed 1,687 across all filing types
Latest filing 2021-05-06 Board/Management Inform…
Country TW Taiwan
Listing TW 1786

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
公告本公司董事會通過總經理異動案
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding a change in the company's general manager, including details about the outgoing and incoming individuals, the effective date, and the reason for the change. It does not contain financial data, audit information, or report content. This fits the category of Board/Management Information, which covers announcements of changes in senior management.
2021-05-06 Chinese
公告本公司董事會決議通過總公司遷址案
Regulatory Filings Classification · 95% confidence The document is a short announcement (640 characters) from a company disclosing a board resolution regarding the relocation of its headquarters. It includes details such as the date of the board meeting, the old and new addresses, and the company's commitment to register the change with authorities. There is no financial data, no mention of financial results, no voting results, no executive changes, no legal proceedings, or other report types. The document is a regulatory announcement about a corporate event (board decision on relocation). It is not a full report, nor a presentation, nor a certification. Given the nature and length, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-05-06 Chinese
110年4月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 科妍, providing information about fund loans and endorsement guarantees for the current and previous months, with amounts all zero. It is a short, factual update without detailed financial statements or analysis. There is no indication of a full report, audit, or management discussion. The content fits the profile of a regulatory announcement or compliance disclosure rather than a full financial report or presentation. Given the short length and nature of the data, it aligns best with Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2021-05-06 Chinese
110年4月營業收入
Interim / Quarterly Report Classification · 95% confidence The document is a summarized revenue report from a listed company, showing monthly and cumulative net operating revenue figures with percentage changes compared to the previous year. It includes notes on accounting standards (IFRS) and reporting practices. The document length is short (762 characters) and it primarily provides financial data for a specific month and year (民國110年04月, which corresponds to April 2021). This matches the characteristics of an Interim / Quarterly Report (IR), as it contains substantive financial data for a period shorter than a full fiscal year. It is not an announcement or a brief summary but actual financial figures and explanations, so it is not RPA or RNS. Therefore, the correct classification is IR with high confidence. Q1 2021
2021-05-06 Chinese
110年第1季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated cash flow statement for the first quarter of the year 110 (Taiwanese calendar), which corresponds to 2021. It includes detailed financial data such as cash flows from operating, investing, and financing activities, with specific amounts and accounting items. The presence of actual financial statements and substantive financial data for a quarterly period indicates this is a financial report for a period shorter than a full fiscal year. The document length is 1985 characters, which is relatively short but contains detailed financial data, so it is not merely an announcement or a certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2021
2021-05-06 Chinese
110年第1季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated comprehensive income statement for the first quarter of the year 110 (Taiwan calendar, corresponding to 2021). It includes detailed financial data such as revenue, costs, expenses, net income, and earnings per share for the quarter ending March 31, 2021, compared to the same period in the previous year. The presence of actual financial figures and the quarterly period covered indicate this is a financial report for a period shorter than a full fiscal year. The document length is about 1990 characters, which is relatively short but contains substantive financial data, so it is not merely an announcement or a certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2021
2021-05-06 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.